Skip to main content
SpringerLink
Log in

Acute Drug Reactions and Anaphylaxis

  • Chapter
Handbook of Hematologic and Oncologic Emergencies

  • 64 Accesses

Abstract

Although allergic reactions to antineoplastic agents in general are uncommon, some agents do cause allergic reactions with a reported incidence as high as 40%.1,2 As the use of antineoplastic agents increases, it can be expected that the number of allergic reactions to these drugs will also increase.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Weiss RB: Hypersensitivity reactions to cancer chemotherapy. Semin Oncol 9: 5–13, 1982.

    PubMed  CAS  Google Scholar 

  2. Weiss RB, Bruno S: Hypersensitivity reactions to cancer chemotherapeutic agents. Ann Intern Med 94: 66–72, 1981.

    Article  PubMed  CAS  Google Scholar 

  3. Gell PHG, Coombs RRA: Clinical Aspects of Immunology. Oxford, Blackwell, 1975.

    Google Scholar 

  4. Kreamer KM: Anaphylaxis resulting from chemotherapy. Oncol Nurs Forum 8: 13–16, 1981.

    PubMed  CAS  Google Scholar 

  5. Kelly JF, Patterson R: Anaphylaxis, course, mechanisms and treatment. J. Am Med Assoc 227: 1431–1436, 1974.

    Article  CAS  Google Scholar 

  6. Rana AN, Luskin A: Immunosuppression, autoimmunity and hypersensitivity. Heart Lung 9: 651–657, 1980.

    PubMed  CAS  Google Scholar 

  7. Parker CW: Drug allergy, part one. N Engl J Med 292: 511–514, 1975.

    Article  PubMed  CAS  Google Scholar 

  8. Parker CW: Drug allergy, part two. N Engl J Med 292: 732–736, 1975.

    Article  PubMed  CAS  Google Scholar 

  9. Sheffer AL, Pennoyer DS: Management of adverse drug reactions. J Allergy Clin Immunol 74: 580–588, 1984.

    Article  PubMed  CAS  Google Scholar 

  10. Parker CW: Drug allergy, part three. N Engl J Med 292: 957–960, 1975.

    Article  PubMed  CAS  Google Scholar 

  11. Evans WE, Tsiastis A, Rivera G, et al: Anaphylactic reactions to Escherichia coli and Erwinia asparaginase in children with leukemia and lymphoma. Cancer 49: 1378–1383, 1982.

    Article  PubMed  CAS  Google Scholar 

  12. Spiegel RJ, Echelberger CK, Poplack DG: Delayed allergic reactions following intramuscular L-asparaginase. Med Pediatr Oncol 8: 123–125, 1980.

    Article  PubMed  CAS  Google Scholar 

  13. Killander D, Dohiwitz A, Engtedt L, et al: Hypersensitive reactions and antibody formation during L-asparaginase treatment of children and adults with acute leukemia. Cancer 37: 220228, 1976.

    Google Scholar 

  14. Ohnuma T, Holland JF, Meyer P: Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E. coli. Cancer 30: 376–381, 1972.

    Article  PubMed  CAS  Google Scholar 

  15. Spiegel RJ: The acute toxicities of chemotherapy. Cancer Treatment Rev 8: 197–207, 1981.

    Article  CAS  Google Scholar 

  16. King OY, Wilber JR, Mumford DM, et al: Therapy with Erwinia L-asparaginase in children with acute leukemia after anaphylaxis to E. coli L-asparaginase. Cancer 33: 611–614, 1974.

    Article  PubMed  CAS  Google Scholar 

  17. Dellinger CT, Miale TD: Comparison of anaphylactic reactions to asparaginase derived from Escherichia coli and from Erwinia cultures. Cancer 38: 1843–1846, 1976.

    Article  PubMed  CAS  Google Scholar 

  18. Von Hoff DD, Schilsky R, Reichert CM, et al: Toxic effects of cis-dichlorodiammineplatinum (II) in man. Cancer Treatment Rep 63: 1527–1531, 1979.

    Google Scholar 

  19. Khan A, Hill JM, Grater W, et al: Atopic hypersensitivity to cis-dichlorodiammineplatinum (II) and other platinum complexes. Cancer Res 35: 2766–2770, 1975.

    PubMed  CAS  Google Scholar 

  20. Vogl SE, Zaravinos T, Kaplan BH: Toxicity of cis-diamminedichloroplatinum (II) given in a two-hour outpatient regimen of diuresis and hydration. Cancer 45: 11–15, 1980.

    Article  PubMed  CAS  Google Scholar 

  21. Wiesenfeld M, Reinders E, Corder M, et al: Successful re-treatment with cis-dichlorodiammineplatinum (II) after apparent allergic reactions. Cancer Treatment Rep 63: 219–221, 1979.

    CAS  Google Scholar 

  22. Lorenz W, Doenicke A, Schonina B, et al: HI and H2 receptor antagonists for premedication in anesthesia and surgery: A critical view based on randomized clinical trials with haemaccel and various antiallergic drugs. Agents Actions 10: 114–124, 1980.

    Article  PubMed  CAS  Google Scholar 

  23. Blum RH, Carter SK, Agre K: A clinical review of bleomycin, a new antineoplastic agent. Cancer 31: 903–914, 1973.

    Article  PubMed  CAS  Google Scholar 

  24. Levy RL, Chiarillo S: Hyperpyrexia, allergic-type response and death occurring with low-dose bleomycin administration. Oncology 37: 316–317, 1980.

    Article  PubMed  CAS  Google Scholar 

  25. Yagoda A, Mukherji B, Young C, et al: Bleomycin, an antitumor antibiotic, clinical experience in 274 patients. Ann Intern Med 77: 861–870, 1972.

    Article  PubMed  CAS  Google Scholar 

  26. Inbar MJ, Baratz M, Finger A, et al: Idiosyncratic reaction to bleomycin in an epithelial tumor. Cancer Chemother Pharmacol 13: 71–72, 1984.

    Article  PubMed  CAS  Google Scholar 

  27. Arnold DJ, Stafford CT: Systemic allergic reaction to adriamycin. Cancer Treatment Rep 63: 150–151, 1979.

    CAS  Google Scholar 

  28. Bickers J, Benjamin R, Wilson LL, et al: Rubidazone in adults with previously treated acute leukemia and blast cell phase of chronic myelocytic leukemia: A Southwest Oncology Group Study. Cancer Treatment Rep 65: 427–430, 1981.

    CAS  Google Scholar 

  29. Murti L, Horsman LR: Acute hypersensitivity reaction to cyclophosphamide. J Pediatr 94: 844–845, 1979.

    Article  PubMed  CAS  Google Scholar 

  30. Karchmer RK, Hansen VL: Possible anaphylactic reaction to intravenous cyclophosphamide. J Am Med Assoc 237: 475, 1977.

    Article  CAS  Google Scholar 

  31. Lakin JD, Cahill RA: Generalized urticaria to cyclophosphamide: Type I hypersensitivity to an immunosuppressive agent. J Allergy Clin Immunol 58: 160–171, 1976.

    Article  PubMed  CAS  Google Scholar 

  32. Grunnet E: Contact urticaria and anaphylactoid reaction induced by topical application of nitrogen mustard. Br J Dermatol 94: 101–103, 1976.

    Article  PubMed  CAS  Google Scholar 

  33. Daughters D, Zackheim H, Maibach H: Urticaria and anaphylactoid reactions after topical application of mechlorethamine. Arch Dermatol 107: 429–430, 1973.

    Article  PubMed  CAS  Google Scholar 

  34. Constantine VS, Fuks ZY, Farber EM: Mechlorethamine desensitization in therapy for mycosis fungoides. Arch Dermatol 111: 484–488, 1975.

    Article  PubMed  CAS  Google Scholar 

  35. Lawrence BV, Harvey HA, Lipton A: Anaphylaxis due to oral melphalan. Cancer Treatment Rep 64: 731–732, 1980.

    CAS  Google Scholar 

  36. Cornwell GG, Pajak TF, McIntyre OR: Hypersensitivity reactions to IV melphalan during treatment of multiple myeloma: Cancer and Leukemia Group B experience. Cancer Treatment Rep 63: 399–403, 1979.

    Google Scholar 

  37. Goldberg NH, Romolo JL, Austin EH, et al: Anaphylactoid type reactions in two patients receiving high dose intravenous methotrexate. Cancer 41: 52–55, 1978.

    Article  PubMed  CAS  Google Scholar 

  38. Klimo P, Ibrahim E, Anaphylactic reaction to methotrexate used in high doses as an adjuvant treatment of osteogenic sarcoma. Cancer Treatment Rep 65: 725, 1981.

    CAS  Google Scholar 

  39. Gluck-Kuyt I, Irwin LE: Anaphylactic reaction to high dose methotrexate. Cancer Treatment Rep 63: 797–798, 1979.

    CAS  Google Scholar 

  40. Rassiga AL, Schwartz HJ, Forman WB, et al: Cytarabine-induced anaphylaxis, demonstration of antibody and successful desensitization. Arch Intern Med 140: 425–426, 1980.

    Article  PubMed  CAS  Google Scholar 

  41. Markman M, Howell SB, King M, et al: Anaphylactic reaction to cytarabine: In vitro evidence that the response is immunoglobulin E mediated. Med Pediatr Oncol 12: 201–203, 1984.

    Article  CAS  Google Scholar 

  42. Gassel WD, Gropp C, Havemann K: Acute allergic reaction due to vincristine sulfate, a case report. Oncology 41: 403–405, 1984.

    Article  PubMed  CAS  Google Scholar 

  43. O’Dwyer PJ, Weiss RB: Hypersensitivity reactions induced by etoposide. Cancer Treatment Rep 68: 959–961, 1984.

    Google Scholar 

  44. Seiler RW, Vassella F, Markwalder H: Combination chemotherapy with VM-26 and CCNU in primary malignant brain tumors. Surg Neurol 11: 237–242, 1979.

    PubMed  CAS  Google Scholar 

  45. Lassus M, Scott D, Leyland-Jones B: Allergic reactions associated with Cremophor containing antineoplastics. Proc Am Soc Clin Oncol 4: 268, 1985.

    Google Scholar 

  46. Minutes: Phase I-II Meetings. National Cancer Institute, Bethesda, Maryland, 1985.

    Google Scholar 

  47. Budman DR, Schulman P, Vinciguerra V, et al: Anaphylactoid reaction to AZQ. Cancer Che-mother Pharmacol 8: 317, 1982.

    CAS  Google Scholar 

  48. Rosenfelt FP, Rosenbloom BE, Weinstein IM: Allergic reaction following administration of AMSA. Cancer Treatment Rep 66: 594–595, 1982.

    CAS  Google Scholar 

  49. Welt S, Dellaquila C, Arlin ZA: Allergic reaction following administration of AMSA. Cancer Treatment Rep 65: 919, 1981.

    CAS  Google Scholar 

  50. National Cancer Institute Brochure on Taxol (NSC 125973). Division of Cancer Treatment, National Cancer Institute, Bethesda, Maryland, September, 1983.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, Albert Einstein Cancer Center/Montefiore Medical Center, Bronx, New York, 10467, USA

    Janice Johnstone Strauman R.N., M.N.

  2. Columbia University School of Nursing, New York, New York, 10032, USA

    Janice Johnstone Strauman R.N., M.N.

Authors
  1. Janice Johnstone Strauman R.N., M.N.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Medical Oncology, Department of Medicine, Albert Einstein College of Medicine, 10461, Bronx, New York, USA

    Janice P. Dutcher M.D. (Associate Professor of Medicine) (Associate Professor of Medicine)

  2. Department of Oncology, Montefiore Medical Center, 10461, Bronx, New York, USA

    Janice P. Dutcher M.D. (Associate Professor of Medicine) (Associate Professor of Medicine)

  3. Department of Oncology, Montefiore Medical Center, 10467, Bronx, New York, USA

    Peter H. Wiernik M.D. (Gutman Professor and Chairman, Director, Associate Director for Clinical Research) (Gutman Professor and Chairman, Director, Associate Director for Clinical Research)

  4. Division of Medical Oncology, Albert Einstein College of Medicine, 10467, Bronx, New York, USA

    Peter H. Wiernik M.D. (Gutman Professor and Chairman, Director, Associate Director for Clinical Research) (Gutman Professor and Chairman, Director, Associate Director for Clinical Research)

  5. Albert Einstein Cancer Center, 10467, Bronx, New York, USA

    Peter H. Wiernik M.D. (Gutman Professor and Chairman, Director, Associate Director for Clinical Research) (Gutman Professor and Chairman, Director, Associate Director for Clinical Research)

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer Science+Business Media New York

About this chapter

Cite this chapter

Strauman, J.J. (1987). Acute Drug Reactions and Anaphylaxis. In: Dutcher, J.P., Wiernik, P.H. (eds) Handbook of Hematologic and Oncologic Emergencies. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0476-8_28

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-0476-8_28

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-0478-2

  • Online ISBN: 978-1-4899-0476-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation